Chargement

Slzii.com Recherche

Recherche (Nouvelles)

Briacell Presentations Highlight Positive Clinical Data For Bria-IMTTM At ASCO 2026

english top health

(MENAFN - GlobeNewsWire - Nasdaq) Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Quality of Life (QOL) data from the ongoing Phase 3 ...
2026-05-22 07:31:51

Que fais-tu?
0.091824054718018


Nouvelles
Nouvelles

Dernières nouvelles et titres
(MENAFN - GlobeNewsWire - Nasdaq) Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Qua...
Nouvelles